Community Translations

Community Translations

Paradigm-changing osimertinib approval in front-line for advanced NSCLC

Author:: Jane De Lartigue, PhD

Read More

Community Translations

BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy

Author:: Jane De Lartigue, PhD

Read More

Community Translations

Venetoclax approved to treat CLL patients regardless of genotype

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

Nivolumab and ipilimumab combination promises new standard of care for advanced RCC

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

Neratinib extends adjuvant treatment of patients with HER2-positive breast cancer

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

More biosimilars reach the market in efforts to improve access and cut costs

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

First CAR T-cell therapy approvals bolster booming immunotherapy market

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

Lenalidomide becomes standard of care for multiple myeloma in the maintenance setting

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Community Translations

Expanded approval for daratumumab in multiple myeloma

Author:: Edited by Jame Abraham; MD; FACP; report prepared by Jane de Lartigue; PhD

Read More

Community Translations

Bevacizumab-awwb becomes first biosimilar approved for cancer treatment

Author:: Jane De Lartigue

Read More

Community Translations

Trastuzumab-dkst approval adds to the biosimilar cancer drug market

Author:: Edited by Jame Abraham; report by Jane de Lartigue

Read More

Pages